(Q38396964)

2 September 2017

1 reference

title

Atherosclerosis in rheumatoid arthritis: is it all about inflammation? (English)

1 reference

2 September 2017

0 references

1 reference

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825281%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Ian Bruce

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825281%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Sarah Skeoch

series ordinal

1

1 reference

2 September 2017

Ian N Bruce

series ordinal

2

1 reference

2 September 2017

language of work or name

English

0 references

publication date

31 March 2015

1 reference

Nature Reviews Rheumatology

2 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825281%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825281%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825281%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

390-400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825281%20AND%20SRC:MED&resulttype=core&format=json

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Patterns of cardiovascular risk in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Inflammation in atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Reanalysis of the final results of the European Carotid Surgery Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

A tale of two diseases: atherosclerosis and rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Assessment and treatment of endothelial dysfunction in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Cardiovascular risk factors have larger impact on endothelial function in self-reported healthy women than men in the HUNT3 Fitness study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Inflammation and immune system interactions in atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Inflammation, atherosclerosis, and coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Pathophysiology of atherosclerosis plaque progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Sustained acceleration in carotid atherosclerotic plaque progression with intraplaque hemorrhage: a long-term time course study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Vascular function and morphology in rheumatoid arthritis: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Carotid plaque characteristics and disease activity in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Genetic susceptibility to rheumatoid arthritis: an emerging picture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Genes and coronary artery disease: where are we?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Pathway analysis of seven common diseases assessed by genome-wide association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Systematic functional regulatory assessment of disease-associated variants.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Recent advances in the genetics of RA susceptibility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Proinflammatory HLA-DRB1*01-haplotype predisposes to ST-elevation myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Genome-wide linkage analysis of cardiovascular disease biomarkers in a large, multigenerational family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register--the EPIC-2-NOAR Study).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Antibodies to citrullinated peptides and risk of coronary heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Insulin resistance and impaired beta cell function in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Hypertension in rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Genetic markers of cardiovascular disease in rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

The mortality of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten-year followup study of a primary care-based inception cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Arterial hypertension assessed "out-of-office" in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated "white c

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.40

Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of Caucasian female patients.

31 March 2020

1 reference

12 December 2020

Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset

1 reference

12 December 2020

Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study

1 reference

12 December 2020

Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study

1 reference

12 December 2020

Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients?

1 reference

12 December 2020

Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis.

1 reference

12 December 2020

A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot study

1 reference

12 December 2020